Chang Gung Memorial Hospital(TaoYuan)

Taoyuan 33305

0 studies enrolling now · 5 studies all time

What they study most

Adenocarcinoma, Anaplastic Large-Cell Lymphoma, Atrial Fibrillation, Carcinoma, Non-Small-Cell Lung, Non-Hodgkin Lymphoma, Percutaneous Coronary Intervention, Secondary Prevention, Stroke, T-Cell Lymphoma

Studies at this site

• ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas — Completed
• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed
• LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy — Completed
• Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) — Completed
• BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation — Completed